Clinical and Experimental Pharmacology Research Lab
Advancing translational pharmacology through innovative research, therapeutic discovery, and a commitment to safer healthcare
Neuroprotective effect of PPAR gamma agonist in rat model of autism spectrum disorder: role of Wnt/β-catenin pathway
Wnt Signaling Modulators Exhibit Neuroprotective Effects via Combating Astrogliosis and Balancing Synaptic Density at Early and Late Stage Temporal Lobe Epilepsy
Exploring the effect of 6-BIO and sulindac in modulation of Wnt/β-catenin signaling pathway in chronic phase of temporal lobe epilepsy
Neuropharmacology Research
Investigating molecular and cellular mechanisms involved in neurological disorders.
Exploring novel therapeutic strategies for neuroprotection and neuroinflammation.
Preclinical evaluation of emerging neuropharmacological agents primarily focused on epilepsy, neuroinflammation, neuroprotection, neuropathic pain, and molecular mechanisms of neuronal injury, with a particular emphasis on the Nrf2-Keap1 antioxidant pathway and experimental animal models
Neuroprotective effect of PPAR gamma agonist in rat model of autism spectrum disorder: Role of Wnt/β-catenin pathway
Gastrointestinal Pharmacology
- Research on gastrointestinal disorders and mucosal protection.
- Development and evaluation of safer anti-ulcer and gastroprotective therapies.
- Studying gut–drug interactions and inflammatory pathways.
- Study role of siRNA in Colorectal cancer (CRC)
Reproductive Pharmacology
- Advancing research in women’s reproductive health and therapeutics.
- Investigating pharmacological interventions for reproductive disorders.
- Experimental studies on hormonal regulation and reproductive safety.
